Skip to content

Clinical trials

Observational Overweight trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Phase: Observational Country / region: China Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20113
20122
20141
20181
20192
20201
20211
20221
20232
20245
20255
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting9
Recruiting7
Completed6
Unknown status4
Not yet recruiting3
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dong Peng3
First Affiliated Hospital of Chongqing Medical University3
Shanghai Jiao Tong University School of Medicine2
He Eye Hospital1
Hebei Medical University Third Hospital1
Hong Kong Baptist University1
Huazhong University of Science and Technology1
Hubei Hospital of Traditional Chinese Medicine1
Jing Ma1
Nanjing First Hospital, Nanjing Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight31
Obesity29
Diabetes Mellitus, Type 24
Metabolic Syndrome3
Colorectal Neoplasms2
Diabetes Mellitus2
Hypertension2
Renal Insufficiency, Chronic2
Sarcopenia2
Alzheimer Disease1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.